Cutler, Corey <br/><br/>
Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.  [electronic resource] 

 -  Blood  Aug 2013 
 - 1510-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2013-04-495895  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>B-Cell Activating Factor--immunology<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Humans<br/>Male<br/>Middle Aged<br/>Peripheral Blood Stem Cell Transplantation--adverse effects<br/>Prospective Studies<br/>Rituximab<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Young Adult